We are live on ! Find out more
LVACW

LAVA Medtech Acquisition Corp. Warrants
LVACW

Delisted

LVACW was delisted on the 12th of May, 2023.

33 hedge funds and large institutions have $867K invested in LAVA Medtech Acquisition Corp. Warrants in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

6% more funds holding

Funds holding: 3133 (+2)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

25% less capital invested

Capital invested by funds: $1.15M → $867K (-$283K)

Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

LVACW Hedge Fund Activity: Q4 2022 in Review

33 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q4 2022, worth a combined $867K — down 25% from $1.15M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new LVACW positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Castle Creek Arbitrage, opening a new position worth an estimated $14.8K. The largest seller was Basso Capital Management, exiting entirely with an estimated $8K sold.

  • 33 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q4 2022, up from 31 in Q3 2022.
  • Funds reported $867K of LAVA Medtech Acquisition Corp. Warrants stock for Q4 2022, down 25% quarter-over-quarter.
  • 5 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q4 2022 and 3 closed out, a net change of +2 holders.
  • The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q4 2022 was Castle Creek Arbitrage, an estimated $14.8K added.
  • The largest LAVA Medtech Acquisition Corp. Warrants seller in Q4 2022 was Basso Capital Management, an estimated $8K sold.

Based on aggregated 13F filings for Q4 2022.